company background image
SHPM.Y logo

Shanghai Pharmaceuticals Holding OTCPK:SHPM.Y Stock Report

Last Price

US$7.69

Market Cap

US$8.0b

7D

-1.3%

1Y

-19.3%

Updated

25 Mar, 2024

Data

Company Financials +

Shanghai Pharmaceuticals Holding Co., Ltd

OTCPK:SHPM.Y Stock Report

Market Cap: US$8.0b

SHPM.Y Stock Overview

Shanghai Pharmaceuticals Holding Co., Ltd.

SHPM.Y fundamental analysis
Snowflake Score
Valuation3/6
Future Growth3/6
Past Performance2/6
Financial Health5/6
Dividends5/6

Shanghai Pharmaceuticals Holding Co., Ltd Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Shanghai Pharmaceuticals Holding
Historical stock prices
Current Share PriceCN¥7.69
52 Week HighCN¥10.47
52 Week LowCN¥6.54
Beta0.25
1 Month Change-5.76%
3 Month Change4.91%
1 Year Change-19.31%
3 Year Change-21.45%
5 Year Change-31.83%
Change since IPO-38.68%

Recent News & Updates

Recent updates

Shareholder Returns

SHPM.YUS HealthcareUS Market
7D-1.3%0.2%1.3%
1Y-19.3%5.7%29.8%

Return vs Industry: SHPM.Y underperformed the US Healthcare industry which returned 7.2% over the past year.

Return vs Market: SHPM.Y underperformed the US Market which returned 30.4% over the past year.

Price Volatility

Is SHPM.Y's price volatile compared to industry and market?
SHPM.Y volatility
SHPM.Y Average Weekly Movement8.3%
Healthcare Industry Average Movement7.3%
Market Average Movement6.0%
10% most volatile stocks in US Market16.8%
10% least volatile stocks in US Market3.0%

Stable Share Price: SHPM.Y has not had significant price volatility in the past 3 months.

Volatility Over Time: SHPM.Y's weekly volatility (8%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
199447,811Bo Shenhttps://www.sphchina.com

Shanghai Pharmaceuticals Holding Co., Ltd. researches, develops, manufactures, distributes, and retails pharmaceutical and healthcare products in China and internationally. It operates through four segments: Production, Distribution, Retail, and Others. The company offers chemicals and biochemicals, Chinese medicines, healthcare products, and medical devices in various therapeutic areas, including anti-tumor, heart and cerebral vessels, psychoneural, anti-infection, auto-immunity, digestive tract and metabolism, and respiratory system.

Shanghai Pharmaceuticals Holding Co., Ltd Fundamentals Summary

How do Shanghai Pharmaceuticals Holding's earnings and revenue compare to its market cap?
SHPM.Y fundamental statistics
Market capUS$7.97b
Earnings (TTM)US$637.92m
Revenue (TTM)US$35.35b

13.8x

P/E Ratio

0.2x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
SHPM.Y income statement (TTM)
RevenueCN¥254.88b
Cost of RevenueCN¥223.22b
Gross ProfitCN¥31.66b
Other ExpensesCN¥27.06b
EarningsCN¥4.60b

Last Reported Earnings

Sep 30, 2023

Next Earnings Date

Mar 28, 2024

Earnings per share (EPS)1.24
Gross Margin12.42%
Net Profit Margin1.80%
Debt/Equity Ratio64.5%

How did SHPM.Y perform over the long term?

See historical performance and comparison

Dividends

3.6%

Current Dividend Yield

50%

Payout Ratio
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.